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Abstract
Prion diseases are a family of neurodegenerative zoonotic foodborne disorders. Although prions can be transmitted orally,
the mechanism by which prions are incorporated into the intestine remains unclear. Our previous studies have shown that
an abnormal isoform of prion protein (PrP
Sc), which is the main component of prions, was efficiently incorporated into the
intestine in suckling mice but not in weaned mice. Furthermore, suckling SCID mice lacking maternal antibodies showed
decreased uptake of PrP
Sc into the intestine compared with suckling wild-type mice, while the lack of PrP
Sc uptake into the
intestine of suckling SCID mice was rescued by the oral administration of IgG. These findings raise the possibility that the
neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, plays a role in PrP
Sc
incorporation into the intestine. The present immunohistochemical study further showed that the FcR blocker Z-e-
aminocaproic acid (ZAA) inhibited PrP
Sc incorporation into the intestinal villi of suckling mice, supporting the above
mentioned concept. Therefore, our findings provide strong evidence that nFcR and maternal antibodies are involved in
PrP
Sc incorporation into the intestine before the weaning period.
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Introduction
Prion diseases are a unique category of illness, the pathogenesis
of which is related to conformational changes in the normal
protein, PrP
C (cellular prion protein), to a form with a high b-sheet
content, PrP
Sc (abnormal prion protein), that is protease resistant
and infectious [1,2]. These diseases include bovine spongiform
encephalopathy (BSE) in cattle, scrapie in sheep, and Creutzfeldt-
Jakob disease (CJD) in humans. The appearance of variant CJD
(vCJD) has raised public health concerns that BSE might be
transmissible to humans across species through dietary exposure to
BSE-contaminated foodstuffs [3]. In addition, human cases of
vCJD have recently emerged in the UK, many years after the
eradication of BSE from the country, due to the very long
incubation times of prion diseases, which range from months to
decades [2].
Epithelial M cells are considered to be involved in the
transmigration of PrP
Sc from the gut and into the lymphoid
system during oral infection [4]. Results from studies using
artificial M cells have also indicated a role for M cells in prion
absorption [5]. On the other hand, PrP
Sc was detected by
immunohistochemistry in villous lacteals and the submucosal
lymphatic system from 15 min to 3.5 h post-challenge and also in
dendritic-like cells in the draining lymph nodes until 24 h post-
challenge. This suggested a transepithelial pathway for prion entry
through the mucosal epithelium rather than a pathway through M
cells in Peyer’s patches [6]. Therefore, two processes have been
hypothesized to account for intestinal prion entry, the M cell
dependent pathway and the M cell independent pathway. In the
former route, PrP
Sc passes through dendritic cells and accumulates
in mesenteric lymph nodes, prior to invading neurons. On the
other hand, in the M cell independent pathway, PrP
Sc is taken up
by epithelial cell transport and directly accumulates in the enteric
nervous system (ENS). The former is the most accepted pathway,
whereas the latter was only suggested recently [6,7]. Furthermore,
it has been reported that during the suckling and weaning periods,
when Peyer’s patches have not developed sufficiently, some PrP
Sc
was detected in the dome epithelium but most was incorporated
through the villous epithelia of Peyer’s patches. This indicated that
uptake through the villi is important for the intestinal epithelial
invasion of PrP
Sc [8]. In addition, the levels of PrP
Sc incorporated
by suckling SCID mice lacking maternal immunoglobulins (Ig) [9]
were significantly lower than those taken up by wild-type suckling
mice. Interestingly, the amount of PrP
Sc incorporated by suckling
SCID mice was increased when immunoglobulin G (IgG) was
administered orally together with PrP
Sc. It was therefore suggested
that maternal immunoglobulins or the neonatal Fc receptor
(nFcR), which is expressed on columnar epithelial cells and is
responsible for taking up maternal antibodies into the body, play a
role in the incorporation of PrP
Sc through epithelial cells [8].
However, there is no evidence for a relationship among PrP
Sc and
IgG.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17928In the present study, in order to elucidate the role of FcR in
PrP
Sc incorporation, the effect of the FcR blocker Z-e-aminoca-
proic acid (ZAA) (Fig. 1) [10] on PrP
Sc incorporation was
analyzed.
Results
Incorporation of IgG through the Villi is Suppressed by
ZAA in CD-1 and SCID Mice
Immunohistochemistry was applied to detect IgG using sheep
anti-mouse IgG. IgG was detected in the villi in the group in which
only IgG was administered (Fig. 2). On the other hand, the
incorporation of IgG was significantly decreased in the group in
which IgG was administered after Z-e-aminocaproic acid
treatment as well as in the group in which IgG and ZAA were
administered at the same time (Fig. 2). Supporting this
observation, number of IgG-positive cells (cells per area) and ratio
of IgG-positive cells (%) were significantly decreased in the groups
of simultaneous and separate administration of ZAA with IgG
compared to those of IgG administration only. Inhibitory effects of
86.9% and 59.5%, respectively, were detected in the latter two
groups (Table 1). This suggested that ZAA suppressed the
incorporation of IgG due to the inhibition of FcR by ZAA.
Incorporation of PrP
Sc through the Villi is Suppressed by
ZAA in CD-1 Mice
After the effect of ZAA had been confirmed, PrP
Sc was detected
by immunohistochemistry using the T2 antibody. PrP
Sc was
incorporated through the villous epithelium and detected in the
lamina propria in the group in which only PrP
Sc was administered
(Fig. 3). However, the incorporation of PrP
Sc into the villi was
significantly decreased in the group in which PrP
Sc was
administered after ZAA treatment as well as in the group in
which PrP
Sc and ZAA were administered at the same time (Fig. 3).
Such observation was quantitatively confirmed in the terms of
number of PrP
Sc-positive cells (cells per area) and ratio of PrP
Sc-
positive cells (%). Inhibitory effects of 70.1% and 51.5%,
respectively, were seen in the latter two groups (Table 1). This
suggested that ZAA suppressed the incorporation of PrP
Sc by
inhibiting FcR.
Discussion
Although the sites at which prions invade the human body are
disputed, natural infection is supposed to occur orally, especially
through the gut. However, the route of prion disease invasion from
the gut to the central nervous system (CNS) still remains unclear.
Previous reports have shown that immune cells participate in the
pathogenesis of murine prion diseases [11,12]. In the oral
transmission route, PrP
Sc moves through the intestinal epithelial
barrier and several other biological barriers before finally reaching
the CNS. To successfully invade through the intestinal epithelial
barrier, pathological agents must avoid digestion in the gastroin-
testinal tract. Although normal proteins are digested by gastric
acid in the stomach and various enzymes in the gastrointestinal
tract, most PrP
Sc peptides are not digested because they are
resistant to protease activity due to their abundant b-sheet
structures. After withstanding digestion in the gastrointestinal
tract and reaching the intestinal epithelial wall, the infectious agent
needs to penetrate the intestinal epithelial barrier and reach the
peripheral nervous system.
PrP
Sc was previously detected in the enteric nervous system
(ENS) of an orally challenged rodent model of TSE, suggesting
that PrP
Sc enters the body via the intestinal mucosa [13]. A
number of putative receptors for prions have been reported, with
one of the most interesting receptors being the 37 kDa laminin
receptor precursor (LRP). LRP is incorporated into the 67 kDa
mature laminin receptors (LR) expressed in the intestinal brush
border of 40% of human subjects [14,15]. The mechanism
postulated for the entry of PrP
Sc after its ingestion involves the
binding of PrP
Sc to the LRP followed by its internalization. It is
considered that epithelial M cells might be involved in the
transmigration of PrP
Sc from the gut and into the lymphoid system
[4]. Furthermore, an experiment using artificial M cells also
indicated a role for M cells in prion absorption [5]. PrP
Sc has also
been detected in villous epithelial cells and is resistant to
degradation by gastric juices and intestinal enzymes because of
its abundant stable b-sheet structure.
In a previous study, the amount of PrP
Sc incorporated by
suckling SCID mice lacking maternal immunoglobulins [9] was
significantly lower than that taken up by wild-type suckling mice
[8]. Moreover, the incorporation of PrP
Sc was upregulated when
IgG was administered together with PrP
Sc. Therefore, it was
suggested that maternal immunoglobulins and nFcR play roles in
the incorporation of PrP
Sc through epithelial cells. The nFcR
binds to the IgG antibodies ingested in maternal milk and
transports them through enterocytes to the systemic circulation of
the newborn [16]. Furthermore, it was reported using nFcR-
knockout mice that foreign proteins were complexed with
immunoglobulins and incorporated via immunoglobulin endocy-
tosis during the suckling period [17]. This shows that the Fc
receptor plays a key role in PrP
Sc infection.
In the present study, we focused on the changes in the
incorporation of PrP
Sc and IgG after the blocking of nFcR. As
described, the amount of IgG incorporated was decreased by ZAA
treatment, and the degree of PrP
Sc incorporation in suckling CD-1
mice administered PrP
Sc and ZAA was significantly decreased
compared with that in suckling CD-1 mice who were administered
PrP
Sc alone. These findings support those of our previous reports
and show that nFcR is associated with the incorporation of PrP
Sc
[1]. By contrast, experiments from Klein et al. [18] assessed the
effect of Fcc receptors on prion pathogenesis in mice deficient in
Fcc receptors I, II and III and found no effect on prion
pathogenesis in these knockout mice. To address this discrepancy,
further in vivo experiments using mice with ZAA before and after
prion infection would be necessary to determine the effect of
blocking Fc receptors on disease progression in their model.
Materials and Methods
Experimental Animals
Fifteen-day-old CD-1 mice (Japan CLEA, Tokyo, Japan) were
housed in specific pathogen-free (SPF) conditions under an
alternating 14 h/10 h light/dark cycle. The animals were given
free access to standard laboratory food (Oriental Yeast Co., Ltd.,
Figure 1. Structure of Z-e-aminocaproic acid (ZAA). Z-e-
aminocaproic acid is a derivative form of e-aminocaproic acid which
is an analogue of the amino acid lysine.
doi:10.1371/journal.pone.0017928.g001
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the procedures authorized by the Animal Experiment Committee
of Nihon University College of Bioresource Sciences. This
experiment was permitted by the guidelines for the care and use
of laboratory animals approved by the College of Bioresource
Science, Nihon University (permit number; NUBS-V168).
Administration of IgG with ZAA
To confirm the effect of ZAA (patent No.: WO2004/058747), a
derivative form of e-aminocaproic acid [10], the following two
experiments were performed: First, 15-day-old CD-1 and SCID
mice (n=3) were administered phosphate buffered saline (PBS)
containing ZAA (30 mg/ml). Then, IgG (5 mg/ml) was admin-
istered 2 h later. The administration of IgG was repeated 3 h later,
and the mice were euthanized with ether at 1 h post-administra-
tion (p.a.). In the second experiment, the same age mice were
administered IgG (5 mg/ml) diluted with PBS containing ZAA
(30 mg/ml). The administration of IgG was repeated 3 h later,
and the mice were euthanized with ether at 1 h post-administra-
tion (p.a.).
Administration of PrP
Sc with ZAA
Two experiments were performed in order to investigate
whether the Fc receptor inhibitor, ZAA, affects the incorporation
of PrP
Sc. First, 15-day-old CD-1 mice (n=3) were administered
PBS containing ZAA (30 mg/ml). After 2 h, they were then
administered 10 mg/ml emulsion of mouse brains infected with
mouse-adapted scrapie (PrP
Sc) (Tsukuba 1 strain [19]) diluted with
PBS containing ZAA (30 mg/ml). Then, the administration of
PrP
Sc was repeated 3 h later, and the mice were euthanized with
ether at 1 h post-administration (p.a.). In the second experiment,
Figure 2. Incorporation of IgG through the villi. Histochemical analysis of IgG in the intestinal villi of 15-day-old CD-1 mice that had been orally
administered IgG (A: IgG), IgG after ZAA treatment (B: IgG after ZAA), or IgG and ZAA at the same time (C: IgG + ZAA). IgG was readily incorporated
into the villi in A and partially incorporated in B and C. The number and percentage of ileal epithelial cells incorporating IgG were significantly higher
in A than B and C. As a negative control, IgG was stained without exogenous IgG as D. The number of IgG-positive cells (E) and the ratio of IgG-
positive cells (F) are expressed as the mean 6 SD. The statistical significance of differences compared to oral administration of IgG was determined
using One-way analysis of variance followed with Tukey’s Multiple Comparison Test (Prism 4.03, GraphPad Software, Inc., La Jolla, CA, USA). **p,0.01.
doi:10.1371/journal.pone.0017928.g002
Table 1. The inhibitory effect of ZAA on the incorporation of
IgG and PrP
Sc on the basis of the ratio of IgG- or PrP
Sc-positive
cells.
Treatment
Inhibitory
effect[%]
Incorporation
of IgG in CD-1 mice
Administration
of IgG after ZAA treatment
86.968.9
Simultaneous administration
of ZAA and IgG
59.5619
Incorporation
of PrP
Sc in CD-1 mice
Administration of PrP
Sc after
ZAA treatment
70.1618.7
Simultaneous administration
of ZAA and PrP
Sc
51.5618.5
doi:10.1371/journal.pone.0017928.t001
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mouse brains infected with mouse-adapted scrapie diluted with
PBS containing ZAA (30 mg/ml). Then, the administration of
PrP
Sc was repeated 3 h later, and mice were euthanized with ether
at 1 h post-administration (p.a.) the.
Preparation of Tissue Specimens
After the mice had been euthanized with ether, their intestines
were removed and fixed by immersion in PBS containing 4%
paraformaldehyde for 2 h before being washed in PBS containing
6.8% sucrose. After dehydration in 100% acetone for 1 h, the
tissue samples were embedded in resin (Technovit 8100; Heraeus
Kulzer, Wehrheim, Germany) in accordance with the manufac-
turer’s instructions and sectioned at a thickness of 4 mm.
Immunohistochemistry for IgG and PrP
The resin sections obtained from the mice treated with IgG were
pretreated with 0.1% CaCl2 at pH 7.8 containing 0.01% trypsin for
10 min at 37uC and then quenched in 0.3% hydrogen peroxide in
methanol for 30 min. For IgG detection, goat anti-mouse IgG
antibody (4 mg/ml; Nichirei, Tokyo, Japan) was directly incubated at
room temperature for 30 min. For detection, incubation with mouse
anti-PrP monoclonal antibody (T2, 10 mg/ml) was performed at
37uC for 2 h followed by incubation with goat anti-mouse IgG
antibody (4 mg/ml; Nichirei, Tokyo, Japan) for 30 min. Diamino-
benzidine (DAB; Wako, Osaka, Japan) was applied for 10 min, and
then the sections were counterstained with hematoxylin for 1 min.
The number of IgG positive cells in each microscopic visual field was
counted at five random points in the villous epithelium. Cell counts
are expressed as the mean 6SD of microscopic fields viewed at6400
magnification. Intestinal epithelial cells were used to determine the
intensity of infection, which was not known to the observer assessing
the respective intestinal sections. And the inhibitory effect was
calculated as the following formula.
The inhibitory effect = (percentage of ileal epithelial cells
incorporating IgG orPrP
Sc with ZAA treatment)/(percentage of
ileal epithelial cells incorporating IgG orPrP
Sc without ZAA
treatment) 6100
The statistical significance of differences compared to oral
administration of IgG or PrP
Sc was determined using One-way
analysis of variance followed with Tukey’s Multiple Comparison
Test (Prism 4.03, GraphPad Software, Inc., La Jolla, CA, USA)
and the inhibitory effect was analyzed by student’s t-test. * p,0.05
**p,0.01.
Figure 3. Incorporation of PrP
Sc through the villi in CD-1 mice. Histochemical analysis of PrP
Sc in the intestinal villi of 15-day-old CD-1 mice
that had been orally administered PrP
Sc (A: PrP
Sc), PrP
Sc after ZAA treatment (B: PrP
Sc after ZAA), or PrP
Sc and ZAA at the same time (C: PrP
Sc + ZAA).
The number and percentage of ileal epithelial cells incorporating PrP
Sc were significantly lower in B and C than in A. D shows the staining of the PrP
without exogenous PrPSc supplementation as a negative control. In our study, we could not detect the normal PrP. The number of PrP
Sc-positive cells
(E) and the ratio of PrP
Sc-positive cells (F) are expressed as the mean 6 SD. The statistical significance of differences compared to oral administration
of PrP
Sc was determined using One-way analysis of variance followed with Tukey’s Multiple Comparison Test (Prism 4.03, GraphPad Software, Inc., La
Jolla, CA, USA). *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0017928.g003
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